Thus, our nanotoxin approach aims to overcome tumor resistance and increase cure rates in HNSCC, by switching cell death induction from apoptosis to caspase-3/GSDME-dependent pyroptosis, as pursued in other cancer types [34, 37, 41]. Here, CASP3 is linked to cancer.